209 related articles for article (PubMed ID: 12972304)
1. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
Gowda RV; Henk JM; Mais KL; Sykes AJ; Swindell R; Slevin NJ
Radiother Oncol; 2003 Aug; 68(2):105-11. PubMed ID: 12972304
[TBL] [Abstract][Full Text] [Related]
2. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
3. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
Reddy SP; Hong RL; Nagda S; Emami B
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
[TBL] [Abstract][Full Text] [Related]
7. Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.
Cacicedo J; Casquero F; del Hoyo O; Gomez-Iturriaga A; Martinez-Indart L; Lopez JL; Bilbao P
Clin Transl Oncol; 2013 Nov; 15(11):925-31. PubMed ID: 23519536
[TBL] [Abstract][Full Text] [Related]
8. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
9. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
10. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
Reddy SP; Mohideen N; Marra S; Marks JE
Radiother Oncol; 1998 May; 47(2):161-6. PubMed ID: 9683364
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
[TBL] [Abstract][Full Text] [Related]
14. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
Pham TA; De Freitas R; Sigston E; Vallance N
ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
[TBL] [Abstract][Full Text] [Related]
15. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
Yu E; Shenouda G; Beaudet MP; Black MJ
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis.
Rudoltz MS; Benammar A; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):767-72. PubMed ID: 8344844
[TBL] [Abstract][Full Text] [Related]
17. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
18. Accelerated radiotherapy for T1 to T2 glottic cancer.
Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
[TBL] [Abstract][Full Text] [Related]
19. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
20. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
